Skip to main content
. 2024 Sep 11;25(18):9816. doi: 10.3390/ijms25189816

Figure 6.

Figure 6

(a) Capture efficiency of NSCLC cell lines in spiked lysed blood using anti-EpCAM antibody, rVAR2, or their combination. (b) Nonspecific capture in spiked lysed blood for the same conditions. Columns represent the mean capture efficiency and nonspecific capture, with whiskers indicating the standard deviation (SD) for n = 3. Statistical significance is denoted by *** (p < 0.001), indicating that the combination of anti-EpCAM and rVAR2 significantly improves capture efficiency compared with using either marker alone.